BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2008
View Archived Issues
PDC and Theratechnologies sign license agreement for PDC-31
Read More
New treatments for cancer reported in recent patent literature
Read More
Oncolin announces results from preclinical animal testing of ONC-127 in cancer
Read More
GlaxoSmithKline reviews first quarter 2008 highlights
Read More
Terguride receives orphan drug designation for pulmonary arterial hypertension
Read More
Lpath initiate phase I clinical trial for iSONEP in patients with AMD
Read More
FDA puts Geron's IND application for GRNOPC1 on clinical hold
Read More
AVI BioPharma reports reproducible results from animal trials of AVI-6002 and AVI-6003
Read More
Sirtex initiates clinical trial of SIR-Spheres microspheres in HCC
Read More
Debiopharm enters license agreement for European marketing of Salvacyl/Moapar
Read More
MGH to conduct phase II trial of tesamorelin in growth hormone-deficient abdominal obesity
Read More
Novavax completes enrollment in phase I/IIa clinical trial of pandemic influenza vaccine
Read More
SynCo completes manufacture of ActoGeniX's AG-011 for phase II trial in ulcerative colitis
Read More
Medivir enters agreement with Tibotec for orally active HCV inhibitors
Read More
Pozen transfers IND and NDA for migraine drug Treximet to GSK
Read More
Progen resumes patient enrollment in phase I study of PG-11047 in advanced cancer
Read More
Poniard and Scripps Research Institute enter license agreement for protein kinase inhibitors
Read More
VIA Pharmaceuticals completes enrollment in phase II ACS trial of VIA-2291
Read More
Cerenis completes phase I clinical trial of CER-002 in cardiovascular disease
Read More
Protox initiates dosing in phase II clinical trial of PRX-302 in BPH
Read More
Southwest Foundation for Biomedical Research establishes new spin-off company
Read More
JNJ-17166864, a novel CCR2 antagonist with potential against inflammatory diseases
Read More
New antiinflammatory agents disclosed in recent Epix patents
Read More
Novel analgesic agents described in recent patents
Read More
Novel vaccine effective in murine model of autoimmune ovarian disease
Read More
Phase I results of MSP3-LSP malaria vaccine reported
Read More
Murine version of ACE-011 shows increased bone formation and strength in mouse model of osteoporosis
Read More